Robustness analysis identifies the plausible model of the Bcl-2 apoptotic switch

FEBS Letters

Volumn 581, Issue 26, 2007, Pages 5143-5150

  Chen, Chun ^a   Cui, Jun ^a   Zhang, Wei ^a   Shen, Pingping ^a  

^a NANJING UNIVERSITY   (China)

Author keywords

Apoptosis; Bcl 2 apoptotic switch; Model; Plausibility; Robustness; Ultrasensitivity

Indexed keywords

PROTEIN BAX; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; MATHEMATICAL ANALYSIS; MATHEMATICAL MODEL; PRIORITY JOURNAL; PROTEIN ANALYSIS;

APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; HUMANS; MODELS, BIOLOGICAL; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 35348866243     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2007.09.063     Document Type: Article

References (45)

1. Saikumar P., Dong Z., Mikhailov V., Denton M., Weiberg J.M., and Venkatachalam M.A. Apoptosis: definition, mechanisms, and relevance to disease. Am. J. Med. 107 (1999) 489-506
2. Loo G., Saelens X., Gurp M., MacFarlane J., Martin S., and Vandenabeele P. The role of mitochondrial factors in apoptosis: a Russian roulette with more than one bullet. Cell Death Differ. 9 (2002) 1031-1042
3. Bouchier-Hayes L., Lartigue L., and Newmeyer D.D. Mitochondria: pharmacological manipulation of cell death. J. Clin. Invest. 115 (2005) 2640-2647
4. Adams J.M., and Cory S. The Bcl-2 apoptotic switch in cancer development and therapy. Oncogene 26 (2007) 1324-1337
5. Tsujimoto Y., and Shimizu S. Bcl-2 family: life-or-death switch. FEBS Lett. 466 (2000) 6-10
6. Kim H., Rafiuddin-Shah M., Tu H.C., Jeffers J.R., Zambetti G.P., Hsieh J.J., and Cheng E.H. Hierarchical regulation of mitochondrion-dependent apoptosis by BCL-2 subfamilies. Nat. Cell Biol. 8 (2006) 1348-1358
7. Willis S.N., Fletcher J.I., Kaufmann T., van Delft M.F., Chen L., Czabotar P.E., Ierino H., Lee E.F., Fairlie W.D., Bouillet P., Strasser A., Kluck R.M., Adams J.M., and Huang D.C.S. Apoptosis initiated when BH3 ligands engage multiple Bcl-2 homologs, not Bax or Bak. Science 315 (2007) 856-859
8. Galonek H.L., and Hardwick J.M. Upgrading the BCL-2 network. Nat. Cell Biol. 8 (2006) 1317-1319
9. Youle R.J. Cellular demolition and the rules of engagement. Science 315 (2007) 776-777
10. Dejean L.M., Martinez-Caballero S., and Kinnally K.W. Is MAC the knife that cuts cytochrome c from mitochondria during apoptosis?. Cell Death Differ. 13 (2006) 1387-1395
11. Chipuk J.E., Bouchier-Hayes L., and Green D.R. Mitochondrial outer membrane permeabilization during apoptosis: the innocent bystander scenario. Cell Death Differ. 13 (2006) 1396-1402
12. Stelling J., Sauer U., Szallasi Z., Doyle III F.J., and Doyle J. Robustness of cellular functions. Cell 118 (2004) 675-685
13. Barkai N., and Leibler S. Robustness in simple biochemical networks. Nature 387 (1997) 913-917
14. Alon U., Surette M.G., Barkai N., and Leibler S. Robustness in bacterial chemotaxis. Nature 397 (1999) 168-171
15. Bhalla U.S., and Iyengar R. Robustness of the bistable behavior of a biological signaling feedback loop. Chaos 11 (2001) 221-226
16. von Dassow G., Meir E., Munro E.M., and Odell G.M. The segment polarity network is a robust developmental module. Nature 406 (2000) 188-192
17. Ingolia N.T. Topology and robustness in the Drosophila segment polarity network. PLoS Biol. 2 (2004) 805-815
18. Yang L., MacLellan W.R., Han Z., Weiss J.N., and Qu Z. Multisite phosphorylation and network dynamics of cyclin-dependent kinase signaling in the eukaryotic cell cycle. Biophys. J. 86 (2004) 3432-3443
19. Zi Z., and Sun Z. Robustness analysis of the IFN-γ induced JAK-STAT signaling pathway. J. Comput. Sci. Technol. 20 (2005) 491-495
20. Blüthgen N., and Herzel H. How robust are switches in intracellular signaling cascades?. J. Theor. Biol. 225 (2003) 293-300
21. Savageau M.A. Parameter sensitivity as a criterion for evaluating and comparing the performance of biochemical systems. Nature 229 (1971) 542-544
22. Morohashi M., Winn A.E., Borisuk M.T., Bolouri H., Doyle J., and Kitano H. Robustness as a measure of plausibility in models of biochemical networks. J. Theor. Biol. 216 (2002) 19-30
23. Eißing T., Allgöwer F., and Bullinger E. Robustness properties of apoptosis models with respect to parameter variations and intrinsic noise. IEE Proc. - Syst. Biol. 152 (2005) 221-228
24. Eißing, T., Waldherr, S., Allgöwer, F., Scheurich, P. and Bullinger, E. Steady state and (bi-) stability evaluation of simple protease signalling networks. BioSystems. Available online at http://dx.doi.org/10.1016/j.biosystmes.2007.01.003.
25. Eißing T., Waldherr S., Allgöwer F., Scheurich P., and Bullinger E. Response to bistability in apoptosis: roles of Bax, Bcl-2, and mitochondrial permeability transition pores. Biophys. J. 92 (2007) 3332-3334
26. Ma L., and Iglesias P.A. Quantifying robustness of biochemical network models. BMC Bioinformatics 3 (2002) 38
27. Chen B., Wang Y., Wu W., and Li W. A new measure of the robustness of biochemical networks. Bioinformatics 21 (2005) 2698-2705
28. Legewie S., Blüthgen N., and Herzel H. Quantitative analysis of ultrasensitive responses. FEBS J. 272 (2005) 4071-4079
29. Dlugosz P.J., Billen L.P., Annis M.G., Zhu W., Zhang Z., Lin J., Leber B., and Andrews D.W. Bcl-2 changes conformation to inhibit Bax oligomerization. EMBO J. 25 (2006) 2287-2296
30. Hua F., Cornejo M.G., Cardone M.H., Stokes C.L., and Lauffenburger D.A. Effects of Bcl-2 levels on Fas signaling-induce Capase-3 activation: molecular genetic tests of computational model predictions. J. Immunol. 175 (2005) 985-995
31. Kuwana T., Mackey M.R., Perkins G., Ellisman M.H., Latterich M., Schneiter R., Green D.R., and Newmeyer D.D. Bid, Bax and lipids cooperate to form supramolecular openings in the outer mitochondrial membrane. Cell 111 (2002) 331-342
32. Bhattacharyya A., Mandal D., Lahiry L., Sa G., and Das T. Black tea protects immunocytes from tumor-induced apoptosis by changing Bcl-2/Bax ratio. Cancer Lett. 209 (2004) 147-154
33. Tirado O.M., Mateo-Lozano S., and Notario V. Rapamycin induces apoptosis of JN-DSRCT-1 cells by increasing the Bax:Bcl-Xl ratio through concurrent mechanisms dependent and independent of its mTOR inhibitory activity. Oncogene (2005) 1-10
34. Childs A.C., Phaneuf S.L., Dirks A.J., Philips T., and Leeuwenburgh C. Doxorubicin treatment in vivo causes cytochrome c release and cardiomyocyte apoptosis, as well as increased mitochondrial efficiency, superoxide dismutase activity, and Bcl-2:Bax ratio. Cancer Res. 62 (2002) 4595-4598
35. Chen L., Willis S.N., Wei A., Smith B.J., Fletcher J.I., Hinds M.G., Colman P.M., Day C.L., Adams J.M., and Huang D.C. Differential targeting of prosurvival Bcl-2 proteins by their BH3-only ligands allows complementary apoptotic function. Mol. Cell 17 (2005) 393-403
36. Walensky L.D., Kung A.L., Escher I., Malia T.J., Barbuto S., Wright R.D., Wagner G., Verdine G.L., and Korsmeyer S.J. Activation of apoptosis in vivo by a hydrocarbon-stapled BH3 helix. Science 305 (2004) 1466-1470
37. Letai A., Bassik M.C., Walensky L.D., Sorcinelli M.D., Weiler S., and Korsmeyer S.J. Distinct BH3 domains either sensitize or activate mitochondrial apoptosis, serving as prototype cancer therapeutics. Cancer Cell 2 (2002) 183-192
38. Bagci E.Z., Vodovotz Y., Billiar T.R., Ermentrout G.B., and Bahar I. Bistability in apoptosis: roles of Bax, Bcl-2 and mitochondrial permeability transition pores. Biophys. J. 90 (2005) 1546-1559
39. Saito M., Korsmeyer S.J., and Schlesinger P.H. Bax-dependent transport of cytochrome c reconstituted in pure liposomes. Nat. Cell Biol. 2 (2000) 553-555
40. Dejean L.M., Martinez-Caballero S., Guo L., Hughes C., Teijido O., Ducret T., Ichas F., Korsmeyer S.J., Antonsson B., Jonas E.A., and Kinnally K.W. Oligomeric Bax is a component of the putative cytochrome c release channel MAC, mitochondrial apoptosis-induced channel. Mol. Biol. Cell 16 (2005) 2424-2432
41. Goldbeter A., and Koshland Jr. D.E. An amplified sensitivity arising from covalent modification in biological systems. Proc. Nati. Acad. Sci. USA 78 (1981) 6840-6844
42. Yi X., YIN X., and Dong Z. Inhibition of Bid-induced apoptosis by Bcl-2, tBid insertion, Bax translocation, and Bax/Bax oligomerization suppressed. J. Biol. Chem. 278 (2003) 16992-16999
43. von Ahsen O., Renken C., Perkins G., Kluck R.M., Bossy-Wetzel E., and Newmeyer D.D. Preservation of mitochondrial structure and function after Bid- or Bax-mediated cytochrome c release. J. Cell Biol. 150 (2000) 1027-1036
44. Tan C., Dlugosz P.J., Peng J., Zhang Z., Lapolla S.M., Plafker S.M., Andrews D.W., and Lin J. Auto-activation of the apoptosis protein Bax increases mitochondrial membrane permeability and is inhibited by Bcl-2. J. Biol. Chem. 281 (2006) 14764-14775
45. Chen C., Cui J., Lu H., Wang R., Zhang S., and Shen P. Modeling of the role of a Bax-activation switch in the mitochondrial apoptosis decision. Biophys. J. 92 (2007) 4304-4315